Swiss National Bank’s Genesis Healthcare, Inc. GEN Stock Holding History

Swiss National Bank’s Portfolio GEN Stock Details GEN Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2017 Q4	–	Sell	-73,500	Closed	-$85K	–	2552
2017 Q3	$85K	Hold	73,500	–	–	﹤0.01%	2526
2017 Q2	$128K	Hold	73,500	–	–	﹤0.01%	2557
2017 Q1	$194K	Hold	73,500	–	–	﹤0.01%	2516
2016 Q4	$312K	Buy	73,500 +18,600	+34%	+$61.3K	﹤0.01%	2511
2016 Q3	$147K	Hold	54,900	–	–	﹤0.01%	2525
2016 Q2	$97K	Hold	54,900	–	–	﹤0.01%	2577
2016 Q1	$122K	Buy	54,900 +12,400	+29%	+$28K	﹤0.01%	2593
2015 Q4	$147K	Hold	42,500	–	–	﹤0.01%	2616
2015 Q3	$261K	Buy	42,500 +6,800	+19%	+$46.1K	﹤0.01%	2433
2015 Q2	$236K	Buy	+35,700	New	+$241K	﹤0.01%	2517

Other funds holding GEN

CPA

Columbia Pacific Advisors Seattle, Washington $31M AUM 29.53% 1-Year Est. Return

HighTower Advisors Chicago, Illinois $103B AUM 28.65% 1-Year Est. Return

FWC

First Washington Corp Seattle, Washington $353M AUM 41.46% 1-Year Est. Return

PGCM

Prescott Group Capital Management Tulsa, Oklahoma $1B AUM 51.95% 1-Year Est. Return

VCM

V3 Capital Management Dallas, Texas $33.4M AUM 5.9% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

Swiss National Bank's GEN Position: Q4 2017 in Review

Swiss National Bank sold out of Genesis Healthcare, Inc. (GEN) in Q4 2017, closing a stake of 73,500 shares — an estimated $85K sold.

Swiss National Bank first reported a position in GEN in Q2 2015 and held it in 10 quarters. The position peaked at $312K in Q4 2016. 68 funds tracked by Wall St. Rank hold GEN as of Q4 2017.

Swiss National Bank reported no remaining Genesis Healthcare, Inc. position as of Q4 2017 after selling out during the quarter.
Swiss National Bank sold 73,500 Genesis Healthcare, Inc. shares in Q4 2017, an estimated $85K.
Swiss National Bank first reported a position in Genesis Healthcare, Inc. in Q2 2015 and held it in 10 quarters.
Swiss National Bank's Genesis Healthcare, Inc. position peaked at $312K in Q4 2016.
68 funds tracked by Wall St. Rank held Genesis Healthcare, Inc. as of Q4 2017.

Based on Swiss National Bank's 13F filing for Q4 2017, filed 7 Feb 2018.